Suppr超能文献

卡介苗膀胱灌注治疗浅表性膀胱肿瘤中白细胞介素-1、白细胞介素-2、白细胞介素-4、白细胞介素-8和肿瘤坏死因子的定位

Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin.

作者信息

Sander B, Damm O, Gustafsson B, Andersson U, Håkansson L

机构信息

Department of Pathology 1., Faculty of Health Sciences, University of Linköping, Sweden.

出版信息

J Urol. 1996 Aug;156(2 Pt 1):536-41. doi: 10.1097/00005392-199608000-00078.

Abstract

PURPOSE

Cytokines have been detected in the urine during the first hours after intravesical Bacillus Calmette Guerin (BCG) treatment against superficial bladder cancer. To investigate the long-lasting mucosal inflammatory response, we analyzed intracellular cytokines by immunohistochemistry in biopsies taken 2 weeks after BCG treatment.

MATERIALS AND METHODS

Tumor biopsies were obtained from 8 patients with noninvasive, papillary transitional cell carcinoma (TCC), and intracellular cytokines were visualized by immunohistochemistry using cytokine-specific monoclonal antibodies.

RESULTS

Interleukin (IL)-1 beta+ or tumor necrosis factor (TNF)-alpha+ cells were abundant in tumor and stroma. Interleukin-1 alpha, IL-2, IL-4, IL-8 and TNF-beta were variably expressed, while IL-10+ and interferon (IFN)-gamma+ cells were not detected. Among the few patients studied (5 responders and 3 nonresponders to BCG treatment) no single cytokine or cytokine profile was associated with clinical response to BCG therapy.

CONCLUSION

We conclude that the in situ cytokine response after BCG treatment is highly complex, since cytokine profiles differed among the 8 patients investigated and between tumor and surrounding tumor-free mucosa. Further studies, investigating larger numbers of patients, is required to clarify whether cytokine profiles correlate with the clinical response to BCG.

摘要

目的

在膀胱内灌注卡介苗(BCG)治疗浅表性膀胱癌后的最初数小时内,尿液中已检测到细胞因子。为了研究持久的黏膜炎症反应,我们通过免疫组织化学分析了BCG治疗2周后活检组织中的细胞内细胞因子。

材料与方法

从8例非侵袭性乳头状移行细胞癌(TCC)患者获取肿瘤活检组织,使用细胞因子特异性单克隆抗体通过免疫组织化学观察细胞内细胞因子。

结果

肿瘤和基质中白细胞介素(IL)-1β+或肿瘤坏死因子(TNF)-α+细胞丰富。白细胞介素-1α、IL-2、IL-4、IL-8和TNF-β表达各异,而未检测到IL-10+和干扰素(IFN)-γ+细胞。在所研究的少数患者(5例对BCG治疗有反应者和3例无反应者)中,没有单一细胞因子或细胞因子谱与BCG治疗的临床反应相关。

结论

我们得出结论,BCG治疗后的原位细胞因子反应高度复杂,因为在所研究的8例患者中以及肿瘤与周围无肿瘤黏膜之间细胞因子谱存在差异。需要进一步研究更多患者,以阐明细胞因子谱是否与BCG的临床反应相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验